Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Study of MLN8237 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for MLN8237 in participants with advanced solid tumors; results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors [Phase 1]
Phase 1 clinical trial of LY2603618 in combination with gemcitabine for solid tumors; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors [Phase 1]
Phase 1 dose-finding and pharmacokinetic study of DpC in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors [Phase 2]
Phase 2 trial evaluating the effect of lurbinectedin on cardiac repolarization in patients with selected solid tumors has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of PF-05082566 in combination with mogamulizumab in patients with advanced solid tumors was terminated; results posted in 2019…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects [Phase 1]
A Phase 1 study evaluating potential drug-drug interactions between tivantinib (ARQ 197) and five concomitant medicines in cancer patients w…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
This update reports the completion of an open-label Phase 1 trial of DS-8273a in subjects with advanced solid tumors or lymphomas, assessing…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors [Phase 1]
A Phase I dose-finding study of melatonin in pediatric patients with relapsed solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers [NA]
This ClinicalTrials.gov record shows a terminated trial evaluating immunostimulating interstitial laser thermotherapy for solid cancers.
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
This is a Phase 1 clinical trial update evaluating SCT-I10A in patients with advanced solid tumors or lymphoma, focusing on safety, tolerabi…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas [Phase 1]
Phase 1 study of eribulin mesylate in pediatric participants with recurrent or refractory solid tumors (excluding CNS) and lymphomas complet…
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer [Phase 1]
Phase I study update of pazopanib and everolimus in advanced solid tumors and previously treated advanced urothelial cancer has completed (r…
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function [Phase 1]
Phase 1 pharmacokinetics study of alisertib in adults with advanced solid tumors or relapsed/refractory lymphoma across varying hepatic func…
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001) [Phase 1]
Phase 1 study MK-5108-001 in patients with advanced or refractory solid tumors has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015) [Phase 1]
Phase 1 study evaluating MK-2206 in combination with trastuzumab and lapatinib for HER2-positive solid tumors; the trial was terminated and …
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib [Phase 1]
Phase 1 pharmacokinetics and metabolism study of alisertib completed; reports mass balance data in advanced solid tumors and lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for C14 in patients with advanced and/or metastatic solid tumors; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Trial of MSC1936369B in Subjects With Solid Tumors [Phase 1]
Phase 1 trial update for MSC1936369B in subjects with solid tumors (cancer) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-22Clinical Trial Update: A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available [Phase 1]
Phase 1 trial evaluating IMC-A12 (avelumab?) in participants with advanced solid tumors; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 dose-escalation study of LY573636-sodium with liposomal doxorubicin in patients with advanced solid tumors has completed with result…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: A Safety Study in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 safety study in participants with advanced solid tumors has been terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002) [Phase 1]
Phase 1 dose-finding study of dalotuzumab (MK-0646) in subjects with advanced solid tumors has completed; results posted.
-
CLINICAL_TRIALS withdrawal · 2018-07-27Clinical Trial Update: Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies [Phase 1]
This Phase 1 trial of alisertib (MLN8237) in combination with brentuximab vedotin for relapsed/refractory CD30-positive lymphomas and CD30-p…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Phase I Study of AT13148, a Novel AGC Kinase Inhibitor [Phase 1]
Phase I study of AT13148, a novel AGC kinase inhibitor, in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Study of Samalizumab in Patients With Advanced Cancer [Phase 1]
Phase 1 study of samalizumab in patients with advanced solid tumors has been terminated.